In melanoma and lung cancer models, impaired phosphorylation of STAT1 in response to IFN-γ results in low MHC induction rate and reduced IFN-γ sensitivity due to defective JAK signal transduction [36]. This evidence concerns the gene STAT1 and melanoma.